|
 Alzheimer's Care
 Merz - our research for your health. In contrast to first generation therapies, Memantine is likely to show neuroprotective effects at concentrations used in the treatment of Alzheimer s disease and to slow down disease progression.
Alzheimer's Care: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Alzheimer's Care is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Alzheimer's Care now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Alzheimer's Care very serious, so that we can offer you the best drug for each treatment and therapy you need. Alzheimer's Care and Merz means research for your health. High-quality products and information about Alzheimer's Care can be found on our website. Visit us online and learn everything about Alzheimer's Care from one of Germany's leading health care companies. Our contribution to Alzheimer's Care: read here what we can do for you. Further links: Axura: Information for professionals.>>
Alzheimer's Care and Merz means research for your health.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . In contrast to first generation therapies, Memantine is likely to show neuroprotective effects at concentrations used in the treatment of Alzheimer s disease and to slow down disease progression. Memantine is well tolerated even in long-term therapy. Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. The 2 large studies have shown positive effects of memantine in mild to moderate cases of vascular dementia. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. At the same time, Memantine reduces caregiver time by more than 50 hours a month. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. Calcium enters into the cell, and through secondary processes, the signal is recognized. This is clearly discernible behind the low background noise. Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. However, due to the already elevated calcium concentration, the signal can no longer be detected (occurrence of dementia symptoms). In contrast to first generation therapies, Memantine is likely to show neuroprotective effects at concentrations used in the treatment of Alzheimer s disease and to slow down disease progression. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Other franchise covered by Merz are hepatology, metabolic diseases and dermatology. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Alzheimer's Care
|
